Open AccessViews of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results
Author(s) -
Paula Fernández Álvarez,
María Belvis Jiménez,
Belén Maldonado Pérez,
Luisa Castro Laria,
Ángel Caunedo Álvarez,
José Luis Rodríguez de Los Ríos,
Federico ArgüellesArias
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7472/2020
Subject(s) - medicine , inflammatory bowel disease , pandemic , covid-19 , disease , inflammatory bowel diseases , virology , infectious disease (medical specialty) , outbreak
the SARS-COV-2 pandemic has forced a substantial change in the care of patients with digestive pathologies, especially for inflammatory bowel disease (IBD) patients taking immunosuppessive medications. In this regard, some national and international guidelines have indicated the standards to be taken into account. However, few studies have evaluated how patients have dealt with this infection. Therefore, this study was performed with the aim to determine how the SARS-COV-2 pandemic has affected our IBD patients.